Market Forecast News: Veterinary Infectious Disease Diagnostics Industry to Hit $4.22B by 2030
The report "Veterinary Infectious Disease Diagnostics Market by Product (Consumables, Instruments), Technology (Molecular Diagnostic, PCR, ELISA, Immunodiagnostics, Rapid Tests), Animal Type (Companion Animal, Livestock), End User & Region - Global Forecast to 2030", is projected to reach USD 4.22 billion by 2030 from USD 2.87 billion in 2025, growing at a CAGR of 8.0%.
Browse through 699 market data tables and 69 figures spread across 547 pages and the in-depth TOC on the “Veterinary Infectious Disease Diagnostics Market - Global Forecast To 2030.”
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/veterinary-infectious-disease-diagnostic-market-221816584.html
The veterinary infectious disease diagnostics market is experiencing significant growth due to several key factors. A primary driver of this growth is the increasing prevalence of infectious diseases in both companion and farm animals, which has led to a higher demand for timely and accurate diagnostic tools. Additionally, growing concerns about the transmission of zoonotic diseases and the economic consequences of animal disease outbreaks are prompting veterinarians and livestock producers to invest in advanced diagnostic methods to effectively prevent and control infections.
Moreover, the rise in pet ownership and the heightened focus on animal welfare are encouraging more routine health screenings and early disease detection, especially in developed regions. Technological advancements in diagnostic methods, such as PCR, ELISA, and molecular-based assays, are further propelling market growth. These technologies offer faster, more sensitive, and user-friendly testing solutions, enhancing disease detection rates and facilitating quicker clinical decision-making.
By product, the consumables segment accounted for the largest market share in 2024.
In the veterinary infectious disease diagnostics market, the consumables segment held the largest market share in 2024. This dominance is primarily driven by the high and recurring demand for diagnostic test kits, reagents, and other consumable supplies used in routine testing for infectious diseases. Consumables are essential in reference laboratories, veterinary clinics, and point-of-care settings for conducting tests such as PCR, ELISA, lateral flow assays, and other molecular and immunodiagnostic procedures.
Unlike instruments, which are usually a one-time capital investment, consumables are utilized on a per-test basis, leading to continuous and increasing demand as testing volumes rise. The growing incidence of infectious diseases among animals, along with heightened awareness of the importance of early diagnosis and prevention, is significantly boosting the use of diagnostic consumables.
By technology, the molecular diagnostics segment is expected to grow at the highest CAGR during the forecast period.
The molecular diagnostics segment is expected to be the fastest-growing area within the veterinary infectious disease diagnostics market due to its superior accuracy, sensitivity, and capability to detect pathogens at an early stage. Techniques such as polymerase chain reaction (PCR), real-time PCR (qPCR), and nucleic acid sequencing have become increasingly important for identifying infectious agents with high precision, even at low concentrations. A key factor driving this growth is the rising prevalence of complex and emerging infectious diseases in both companion and livestock animals, which require advanced and reliable detection methods. Molecular diagnostics provides faster turnaround times and greater specificity than conventional methods, allowing veterinarians to make quicker and more informed treatment decisions.
By region, North America accounted for the largest share of the market in 2024.
In 2024, North America led the veterinary infectious disease diagnostics market, supported by a developed healthcare system and major diagnostic companies. The region boasts advanced diagnostic infrastructure, including reference laboratories and specialized veterinary hospitals. High investment in pet healthcare emphasizes preventive diagnostics and early disease detection. Increased awareness, better insurance coverage, and higher disposable income encourage timely veterinary care among pet owners in the US and Canada. Government initiatives aimed at controlling zoonotic diseases further boost the demand for diagnostics, while a robust regulatory framework ensures quality products and quicker tech approvals.
Key Market Players
The prominent players in the veterinary infectious disease diagnostics market are IDEXX Laboratories, Inc. (US), Zoetis Services LLC (US), Thermo Fisher Scientific Inc. (US), Virbac (France), bioMérieux (France), Antech Diagnostics, Inc. (US), Innovative Diagnostics (France), Neogen Corporation (US), INDICAL BIOSCIENCE GmbH (Germany), and Agrolabo S.p.A. (Italy).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Veterinary Infectious Disease Diagnostics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
